Treatment of Advanced Prostatic Cancer-Reference-Cited by-同舟云学术

Treatment of Advanced Prostatic Cancer

Published:1987-05 Issue:2 Volume:14 Page:353-371
ISSN:0094-0143
Container-title:Urologic Clinics of North America
language:en
Short-container-title:Urologic Clinics of North America

Author:

Sogani Pramod C.,Fair William R.

Publisher

Elsevier BV

Subject

Urology

Reference131 articles.

1. Treatment of advanced prostatic cancer with LHRH analogue 118630: Clinical response and hormonal mechanisms;Ahmed;Lancet,1983

2. Preliminary report on use of depot formulation of LHRH analogue ICI-118630 (Zoladex) in patients with prostatic cancer;Ahmed;Br Med J,1985

3. Estramustine versus conventional estrogen hormones in the initial treatment of highly or moderately differentiated prostatic carcinoma. A randomized study;Anderson;Scand J Urol Nephrol,1980

4. Cancer of the Prostate and Kidney;Anderson,1981

5. The effect of chlorotrianisene (TACE) on kinetics of 3H-testosterone metabolism in patients with carcinoma of the prostate;Baba;Br J Urol,1982

Cited by 45 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolving strategies and application of proteins and peptide therapeutics in cancer treatment;Biomedicine & Pharmacotherapy;2023-07

2. Cancer Treatment Using Peptides: Current Therapies and Future Prospects;Journal of Amino Acids;2012-12-20

3. Is the metalloendopeptidase EC 3.4.24.15 (EP24.15), the enzyme that cleaves luteinizing hormone-releasing hormone (LHRH), an activating enzyme?;REPRODUCTION;2010-02

4. Luteinizing Hormone-Releasing Hormone and Its Agonistic, Antagonistic, and Targeted Cytotoxic Analogs in Prostate Cancer;Drug Management of Prostate Cancer;2010

5. Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone;Nature Clinical Practice Endocrinology & Metabolism;2007-02